跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GANCICLOVIR FOR INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GANCICLOVIR FOR INJECTION USP
Authorized
STANDARD
GANCICLOVIR FOR INJECTION USP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8fee419384b5d250
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
8fee419384b5d250
Drug Approval Canada Name
GANCICLOVIR FOR INJECTION USP
Product Name
GANCICLOVIR FOR INJECTION USP
Status
Marketed
Status Date
2021-07-19
Original Market Date
2021-07-19
Din
02475391
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:18.32
Atc Original
J05AB06 GANCICLOVIR
Atc Name
j 05 ab 06
Aig Number
0128037002
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
GANCICLOVIR (GANCICLOVIR SODIUM)
500 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8fee419384b5d250
Type
Standard
Back to Health Canada Approvals